Hongguang Liu

Shihezi University — China

Medicine · Health Sciences

39h-index4.0kcitations142works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(34), Nanoplatforms for cancer theranostics(29), Medical Imaging Techniques and Applications(25), Monoclonal and Polyclonal Antibodies Research(25), Peptidase Inhibition and Analysis(19)

Publications142 total

Simulating land use change for sustainability: a case study of the northern slope of Tianshan Mountains
International Journal of Digital Earth·2025· 2 citedOpen Access
Impact of task-oriented training based on acupuncture rehabilitation on upper extremity function and quality of life of patients with early stroke
World Journal of Clinical Cases·2024· 1 citedOpen Access
Risk Prediction of Diabetes Progression Using Big Data Mining with Multifarious Physical Examination Indicators
Diabetes Metabolic Syndrome and Obesity·2024· 9 citedOpen Access
Correction to “Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor”
Molecular Pharmaceutics·2023
Amplifying oxidative stress utilizing multiband luminescence of lanthanide nanoparticles for eliciting systemic antitumor immunity
Chemical Engineering Journal·2023· 18 cited
Development of a Novel HER2-Targeted Peptide Probe for Dual-Modal Imaging of Tumors
Journal of Medicinal Chemistry·2023· 19 cited
Dual‐Wavelength Comparative Imaging Based on a Novel NIR‐II/IIb Emissive Rare Earth‐Doped Nanoparticle
Advanced Optical Materials·2023· 9 cited
Supplemental Figure S7 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S3 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S4 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S2 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S1 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
List of legend for supplementary files from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S2 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S6 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S5 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S3 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S1 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Data from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
Supplemental Figure S7 from <sup>18</sup>F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Zhen Cheng(50), Sanjiv S. Gambhir(15), Zheng Miao(13), Gang Ren(9), Kai Cheng(6), Han Jiang(5), Lei Jiang(5), Richard H. Kimura(5), Gang Ren(4), Ning Zhao(4), Yongkuan Suo(4), Fengxia Wu(4), Chunxia Qin(4), Xiaowei Ma(4), Zibo Li(4), Chunrong Qu(3), Ruiqi Liu(3), Jinbo Li(3), Yingding Xu(3), Xiang Hu(3)